Orforglipron - Oral GLP-1 Receptor Agonist Coming Soon | A New Alternative to Ozempic
Great news! On April 1, 2026, a new oral GLP-1 therapy received FDA approval. No more injections like Mounjaro or Ozempic — this new treatment comes in a tablet form, making it easier to use in everyday Foundayo (Orforglipron) works...
